Subscribe
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants. On April 11, Sanofi began production of the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris based on discoveries in the laboratory of Jay Keasling at UC Berkeley.
Tag: developing world
Campus’s ‘socially responsible licensing’ receives Patents for Humanity award
April 11, 2013:
The U.S. Patent and Trademark Office honored UC Berkeley’s technology transfer office for its socially responsible licensing to provide low-cost treatments and technologies to people in developing countries, highlighted by the successful licensing of a discovery leading to a newly launched yeast-derived malaria drug. Other projects are nutritionally fortified sorghum & disease-resistant crops.
Using ionized plasmas as cheap sterilizers for developing world
November 14, 2011:
Devices that create ionized plasmas could be life-savers in the developing world or on the battlefield, providing an inexpensive way to sterilize water and medical instruments.
